Judge approves $7.25bn Bayer settlement over Roundup cancer claims
A Missouri state court has approved Bayer's $7.25bn settlement over lawsuits alleging its Roundup weedkiller causes cancer, clearing most of a legal burden that has weighed on the German company for nearly a decade. Announced in February, the deal resolves roughly 65,000 US state and federal claims from home and workplace users, plus nearly all future claims.
In St Louis on Friday, Judge Timothy Boyer called the agreement "fair, reasonable and adequate," overruling objections that individual payouts were too low compared with earlier deals and warning delays could leave terminally ill victims waiting indefinitely. Bayer CEO Bill Anderson hailed a decisive milestone; Bayer's shares have fallen 46% since its $63bn takeover of Roundup maker Monsanto in 2018.
Bayer settled much of the litigation for $10.9bn in 2020, though a $1.25bn plan for future claims lacked court approval. Maintaining that Roundup's active ingredient, glyphosate, is safe, Bayer reached this deal five months after a 7-2 US Supreme Court ruling overturned a $1.25m award to Missouri plaintiff John Durnell, holding that federal pesticide law bars state failure-to-warn claims. Plaintiffs' lawyer Christopher Seeger said the ruling narrowed court options and welcomed swift relief, though about 200 excluded federal cases remain active.
Continue in the app — vote & join in ➔